TP53I3 and cancer: Furthermore, we demonstrated that loss of PIG3 significantly increases NSCLC cells chemosensitivity to docetaxel, one of the most commonly used chemotherapeutic drugs against multiple cancers including advanced NSCLC [18], via enhancing docetaxel-induced apoptosis and senescence.